$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
绥美凯(Triumeq)的详细说明书:作用与功效,用法用量,副作用,注意事项等
2025-10-19 11:44:20
Check Details
绥美凯(Triumeq)的副作用和不良反应
2025-10-19 11:44:20
Check Details
ViiVHealthcare宣布美国FDA批准绥美凯(Triumeq),这是首款含多替拉韦的分散型单一片剂方案,为感染HIV的儿童提供每日一次治疗u200bu200b
2025-10-19 11:44:20
Check Details
绥美凯(Triumeq)中文说明书
2025-10-19 11:44:20
Check Details
绥美凯(Triumeq)的用法用量:用药指南,剂量调整,特殊人群用药
2025-10-19 11:44:20
Check Details
福替沙韦(Fostemsavir)的详细说明书:作用与功效,用法用量,副作用,注意事项等
2025-10-19 11:44:20
Check Details
福替沙韦(Fostemsavir)的副作用和不良反应
2025-10-19 11:44:20
Check Details
福替沙韦(Fostemsavir)中文说明书
2025-10-19 11:44:20
Check Details
福替沙韦(Fostemsavir)的用法用量:用药指南,剂量调整,特殊人群用药
2025-10-19 11:44:20
Check Details
卡替拉韦(Cabotegravir)的用药注意事项
2025-10-19 11:44:20
Check Details
卡替拉韦(Cabotegravir)是治疗什么疾病的
2025-10-19 11:44:20
Check Details
卡替拉韦(Cabotegravir)的副作用如何缓解
2025-10-19 11:44:20
Check Details
1
2
...
4024
4025
4026
4027
4028
4029
4030
...
10241
10242
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Daraxonrasib Pregnancy, Lactation and Contraception Safety
2
Afatinib Side Effects and Safety Management
3
Capmatinib for MET Exon 14 Non-Small Cell Lung Cancer
4
Ibrutinib for CLL/SLL: Not for Immediate Use at Diagnosis
5
Key points for drug monitoring of Molotinib in bone marrow fibrosis
6
Elacestrant US Approval and Treatment Planning While Not Yet Available Locally
7
Stiripentol in Dravet Syndrome: Growth, Cognitive Development and Long-Term Follow-Up Management
8
FDA Approves Pimicotinib for Symptomatic Tenosynovial Giant Cell Tumor: Mechanism, Dosing and MANEUVER Data
9
Cabozantinib Overview: Multi-Target TKI Efficacy and Safety Monitoring for Bleeding, Hypertension, Thrombosis
10
FDA Approves Sunharbo (asundexian), the World’s First FXIa Inhibitor, to Reduce Stroke Risk in Adults with Recent Non‑Cardioembolic Ischemic Stroke or High‑Risk TIA
11
Sotorasib (Lumakras): Indications, Dosing, Safety and the Next-Gen KRAS G12C Landscape
12
Momelotinib for Myelofibrosis: Spleen Response, Symptom Improvement and Efficacy Monitoring